GPR40 Activator 2

• CAT Number: I001198
• CAS Number: 1312787-30-6
• Molecular Formula: C28H29NO6S2
• Molecular Weight: 539.66
• Purity: ≥95%
• Target: Free Fatty Acid Receptor
• Solubility: 10 mM in DMSO
• Storage: Store at -20°C
• IUPAC Name: 5-[4-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]phenyl]-1-oxo-1,2-thiazol-3-one
• InChI: InChI=1S/C28H29NO6S2/c1-19-14-25(34-12-5-13-37(3,32)33)15-20(2)28(19)23-7-4-6-21(16-23)18-35-24-10-8-22(9-11-24)26-17-27(30)29-36(26)31/h4,6-11,14-17H,5,12-13,18H2,1-3H3,(H,29,30)
• InChIKey: AUYCNSCKGNAXFS-UHFFFAOYSA-N
• SMILES: CC1=CC(=CC(=C1C2=CC(=CC=C2)COC3=CC=C(C=C3)C4=CC(=O)NS4=O)C)OCCCS(=O)(=O)C

GPR40 Activator 2(CAT: I001198) is a selective agonist of the G-protein-coupled receptor 40 (GPR40), also known as the free fatty acid receptor 1 (FFAR1). By enhancing GPR40 signaling, this compound stimulates glucose-dependent insulin secretion, making it a promising tool in the study of metabolic diseases, particularly type 2 diabetes. GPR40 Activator 2 has been shown to modulate pancreatic β-cell function and improve glucose homeostasis, offering insights into receptor-mediated therapeutic strategies. Its high specificity and potency make it a valuable resource for researchers exploring novel approaches to metabolic regulation and diabetes treatment.